FDA Inspection 655775 — Anika Therapeutics, Inc.

Anika Therapeutics, Inc. — FEI 3007093114

The FDA completed an inspection of Anika Therapeutics, Inc. on March 12, 2010 in Bedford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 12, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Bedford, MA (United States)

Additional Details

Sponsor, Contract Research Organization